Market Overview:
The global topical hemostatic agents market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of trauma and surgery, rising awareness about hemostatic agents, and technological advancements in the field of hemostasis. The global topical hemostatic agents market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into gelation sponge, oxidized regenerated cellulose based hemostats (ORC-based hemostats), thrombin-based products (fibrin sealants/adhesives), collagen-based products (collagen sponges/gels), platelet rich plasma therapies (PRP therapies), other types. Gelation sponge held a dominant share in 2017 owing to its easy availability and low cost as compared to other types of topical hemostatic agents. However, ORC-based hemostats are expected to grow at a higher CAGR during the forecast period due to their superior properties such as high clotting activity and biocompatibility.
Product Definition:
Topical hemostatic agents are substances applied to a wound to control bleeding. They work by causing blood vessels to constrict, which reduces the amount of blood flowing through the wound. This helps reduce the amount of blood loss and speeds up the healing process.
Gelation Sponge:
Gelation sponges are made from a gel-forming polymer and are used to collect blood that has coagulated due to injury or surgery. It is also used in the treatment of heavy menstrual bleeding, postpartum hemorrhage, and excessive bleeding for patients suffering from cancer. Gelation sponge is an inert porous material that allows the collection of blood by capillary action.
Oxidized Regenerated Cellulose Based Hemostats:
Oxidized regenerated cellulose (ORC) based hemostats are a group of highly effective agents used to prevent blood loss in patients suffering from angina pectoris and myocardial infarction. The product is also useful for the treatment of hemorrhage caused by injury or disease to the gastrointestinal, hepatic or renal organs. It works by forming a physical barrier across the open wound surface which prevents further damage and helps in promoting healing.
Application Insights:
Based on the application, the topical hemostatic agents market is segmented into hospitals, surgical centers, and nursing homes. Hospitals held the largest share in 2017 owing to an increase in trauma cases and a rise in number of surgeries. In addition, a high prevalence of chronic diseases such as diabetes mellitus and cardiovascular diseases increases healthcare expenditure which subsequently boosts product demand.
The surgical center segment is expected to witness significant growth over the forecast period due to rising awareness about availability of advanced products for preventing postoperative complications including hemorrhage. Furthermore, factors such as increasing number of gynecology surgeries along with aging population are anticipated to drive this application segment during future years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high disposable income, and favorable reimbursement policies. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by major companies and rising adoption of advanced products. In addition, growing prevalence of chronic diseases such as cancer & diabetes is anticipated to boost demand for hemostatic agents in North America.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to improving healthcare facilities & infrastructure coupled with an increase in medical tourism activities supported by low cost treatment options offered by countries such as India & China. Furthermore, government initiatives promoting public health are also estimated contribute towards regional growth over the next eight years.
Growth Factors:
- Increasing incidence of traumatic injuries: The increasing incidence of traumatic injuries is one of the key growth drivers for the global topical hemostatic agents market. Traumatic injuries are caused by external forces that lead to damage in tissues and organs. Such injuries often require surgical intervention to stop the bleeding and repair the damage. This, in turn, is expected to drive demand for topical hemostatic agents in the coming years.
- Growing awareness about benefits of using topical hemostatic agents: There is a growing awareness among healthcare professionals and patients about the benefits of using topical hemostatic agents for controlling bleeding during surgery or other medical procedures. This is likely to boost demand for these products in the coming years.
- Technological advancements: The development of new and innovative products based on advanced technologies is another key growth driver for global topical hemostatic agents market . These products offer better efficacy and safety as compared to traditional ones, thus driving their adoption across various regions worldwide..
Scope Of The Report
Report Attributes
Report Details
Report Title
Topical Hemostatic Agents Market Research Report
By Type
Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others
By Application
Hospitals, Surgical Centers, Nursing Homes
By Companies
Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Ethicon, Vascular Solutions, Marine Polymer Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Topical Hemostatic Agents Market Report Segments:
The global Topical Hemostatic Agents market is segmented on the basis of:
Types
Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Surgical Centers, Nursing Homes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ethicon
- Pfizer
- Baxter International
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences
- B Braun Melsungen
- Gelita Medical
- Ethicon
- Vascular Solutions
- Marine Polymer Technologies
Highlights of The Topical Hemostatic Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gelation Sponge
- Oxidized Regenerated Cellulose Based Hemostats
- Others
- By Application:
- Hospitals
- Surgical Centers
- Nursing Homes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Topical Hemostatic Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Topical hemostatic agents are medications that stop bleeding by clotting blood. They are applied to the skin and work quickly to help stop the bleeding. Topical hemostatic agents can be used on their own or in combination with other treatments, such as bandages or tourniquets, to help control serious bleeding.
Some of the major players in the topical hemostatic agents market are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Ethicon, Vascular Solutions, Marine Polymer Technologies.
The topical hemostatic agents market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Topical Hemostatic Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Topical Hemostatic Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Topical Hemostatic Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Topical Hemostatic Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Topical Hemostatic Agents Market Size & Forecast, 2018-2028
4.5.1 Topical Hemostatic Agents Market Size and Y-o-Y Growth
4.5.2 Topical Hemostatic Agents Market Absolute $ Opportunity
Chapter 5 Global Topical Hemostatic Agents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Topical Hemostatic Agents Market Size Forecast by Type
5.2.1 Gelation Sponge
5.2.2 Oxidized Regenerated Cellulose Based Hemostats
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Topical Hemostatic Agents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Topical Hemostatic Agents Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Surgical Centers
6.2.3 Nursing Homes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Topical Hemostatic Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Topical Hemostatic Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Topical Hemostatic Agents Analysis and Forecast
9.1 Introduction
9.2 North America Topical Hemostatic Agents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Topical Hemostatic Agents Market Size Forecast by Type
9.6.1 Gelation Sponge
9.6.2 Oxidized Regenerated Cellulose Based Hemostats
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Topical Hemostatic Agents Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Surgical Centers
9.10.3 Nursing Homes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Topical Hemostatic Agents Analysis and Forecast
10.1 Introduction
10.2 Europe Topical Hemostatic Agents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Topical Hemostatic Agents Market Size Forecast by Type
10.6.1 Gelation Sponge
10.6.2 Oxidized Regenerated Cellulose Based Hemostats
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Topical Hemostatic Agents Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Surgical Centers
10.10.3 Nursing Homes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Topical Hemostatic Agents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Topical Hemostatic Agents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Topical Hemostatic Agents Market Size Forecast by Type
11.6.1 Gelation Sponge
11.6.2 Oxidized Regenerated Cellulose Based Hemostats
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Topical Hemostatic Agents Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Surgical Centers
11.10.3 Nursing Homes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Topical Hemostatic Agents Analysis and Forecast
12.1 Introduction
12.2 Latin America Topical Hemostatic Agents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Topical Hemostatic Agents Market Size Forecast by Type
12.6.1 Gelation Sponge
12.6.2 Oxidized Regenerated Cellulose Based Hemostats
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Topical Hemostatic Agents Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Surgical Centers
12.10.3 Nursing Homes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Topical Hemostatic Agents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Topical Hemostatic Agents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Topical Hemostatic Agents Market Size Forecast by Type
13.6.1 Gelation Sponge
13.6.2 Oxidized Regenerated Cellulose Based Hemostats
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Topical Hemostatic Agents Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Surgical Centers
13.10.3 Nursing Homes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Topical Hemostatic Agents Market: Competitive Dashboard
14.2 Global Topical Hemostatic Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ethicon
14.3.2 Pfizer
14.3.3 Baxter International
14.3.4 C. R. Bard
14.3.5 The Medicines Company
14.3.6 Anika Therapeutics
14.3.7 Advanced Medical Solutions
14.3.8 Integra LifeSciences
14.3.9 B Braun Melsungen
14.3.10 Gelita Medical
14.3.11 Ethicon
14.3.12 Vascular Solutions
14.3.13 Marine Polymer Technologies
